A carregar...
Opening the OPK Assay Gatekeeper: Harnessing Multi-Modal Protection by Pneumococcal Vaccines
Pneumococcal vaccine development is driven by the achievement of high activity in a single gatekeeper assay: the bacterial opsonophagocytic killing (OPK) assay. New evidence challenges the dogma that anti-capsular antibodies have only a single function that predicts success. The emerging concept of...
Na minha lista:
| Publicado no: | Pathogens |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6963391/ https://ncbi.nlm.nih.gov/pubmed/31652741 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pathogens8040203 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|